Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 1
1950 1
1953 1
1955 1
1960 1
1965 2
1967 5
1968 3
1969 1
1970 1
1971 4
1972 2
1973 5
1974 1
1975 6
1976 8
1977 4
1978 4
1979 5
1980 2
1981 3
1982 3
1983 3
1984 2
1985 1
1988 2
1989 1
1990 1
1991 2
1992 1
1993 1
1994 2
1999 2
2001 1
2003 2
2004 2
2005 1
2006 1
2008 1
2010 1
2011 2
2012 3
2013 1
2014 5
2015 5
2016 3
2017 4
2018 7
2019 7
2020 3
2021 5
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

134 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: G.-fives
Page 1
Showing results for G.-fives sargenti
Search for G.-Fivos Sargentis instead (1 results)
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators. Galimberti V, et al. Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Lancet Oncol. 2013. PMID: 23491275 Free PMC article. Clinical Trial.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
The Sargenti N-2 method.
Sargenti A. Sargenti A. Dent Surv. 1978 Oct;54(10):55-8. Dent Surv. 1978. PMID: 289606 No abstract available.
Sargenti defended.
Rigby JJ. Rigby JJ. J Am Dent Assoc. 1994 May;125(5):498, 500. doi: 10.14219/jada.archive.1994.0083. J Am Dent Assoc. 1994. PMID: 8195487 No abstract available.
Where is it and how much? Mapping and quantifying elements in single cells.
Malucelli E, Fratini M, Notargiacomo A, Gianoncelli A, Merolle L, Sargenti A, Cappadone C, Farruggia G, Lagomarsino S, Iotti S. Malucelli E, et al. Analyst. 2016 Sep 21;141(18):5221-35. doi: 10.1039/c6an01091a. Epub 2016 Jul 21. Analyst. 2016. PMID: 27441316 Review.
Sargenti revisited.
Kamenar AP. Kamenar AP. CDS Rev. 1983 Oct;76(9):24-7. CDS Rev. 1983. PMID: 6577967 No abstract available.
BRCA1/2 germline missense mutations: a systematic review.
Corso G, Feroce I, Intra M, Toesca A, Magnoni F, Sargenti M, Naninato P, Caldarella P, Pagani G, Vento A, Veronesi P, Bonanni B, Galimberti V. Corso G, et al. Eur J Cancer Prev. 2018 May;27(3):279-286. doi: 10.1097/CEJ.0000000000000337. Eur J Cancer Prev. 2018. PMID: 28277317
Intra-canal dissolution of Sargenti paste.
Lu DP, Hersh EV. Lu DP, et al. N Y State Dent J. 1994 Jun-Jul;60(6):43-8. N Y State Dent J. 1994. PMID: 8047313
Although the efficacy and safety of the Sargenti technique have remained controversial for more than a decade, the technique still is widely used by many dentists throughout the world. ...
Although the efficacy and safety of the Sargenti technique have remained controversial for more than a decade, the technique still is …
The Sargenti N2 root canal treatment.
Arzt AH. Arzt AH. Clin Prev Dent. 1981 Jul-Aug;3(4):27-9. Clin Prev Dent. 1981. PMID: 6976871 No abstract available.
134 results